Literature DB >> 11069959

Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice.

O Stiedl1, I Misane, J Spiess, S O Ogren.   

Abstract

The present study examined the involvement of the 5-HT(1A) receptors in classical fear conditioning using the 5-HT(1A) agonist 8-hydroxy-2-(di-n-propyloamino)tetralin hydrobromide (8-OH-DPAT) and the selective "silent" 5-HT(1A) receptor antagonist (N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclo- hexane carboxamide trihydrochloride (WAY 100635). The drugs were administered both subcutaneously and bilaterally into the dorsal hippocampus of male C57BL/6J mice. The training was performed in a single trial in which a tone was followed by a footshock. The retention of context- and tone-dependent fear was examined in separate tests conducted either 1 or 24 hr after training. Subcutaneous 8-OH-DPAT (0.1-1.0 mg/kg), when injected before but not after training, caused a dose-dependent impairment of contextual fear in both 1 and 24 hr tests, whereas tone-dependent fear was less affected. Pretraining intrahippocampal injections of 5.0 microg but not 1.0 microg 8-OH-DPAT caused a severe deficit in contextual fear when tested 24 hr after training. When injected both subcutaneously and intrahippocampally, 8-OH-DPAT induced the 5-HT syndrome, indicative of postsynaptic 5-HT(1A) receptor activation at the dose ranges that impaired fear conditioning. However, the behavioral changes induced by 8-OH-DPAT at the time of training could not account for inhibitory effects of 8-OH-DPAT on fear conditioning. Neither subcutaneous (0.03 mg/kg) nor intrahippocampal (0.5 microg per mouse) WAY 100635 altered context- or tone-dependent fear. However, subcutaneous WAY 100635 blocked both the 5-HT syndrome and the impairment of fear conditioning induced by subcutaneous or intrahippocampal 8-OH-DPAT. In contrast, intrahippocampal WAY 100635 blocked the impairment caused by intrahippocampal but not subcutaneous 8-OH-DPAT, indicating the involvement of extrahippocampal 5-HT(1A) receptors in fear conditioning. It is concluded that the deficits in fear conditioning induced by 8-OH-DPAT are a result of postsynaptic 5-HT(1A) receptor activation that interferes with learning processes operating at acquisition but not consolidation. Furthermore, the dorsohippocampal 5-HT(1A) receptors play an important but not exclusive role in the limbic circuitry subserving contextual fear conditioning.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069959      PMCID: PMC6773161     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  78 in total

Review 1.  Contextual fear, gestalt memories, and the hippocampus.

Authors:  M S Fanselow
Journal:  Behav Brain Res       Date:  2000-06-01       Impact factor: 3.332

2.  The global record of memory in hippocampal neuronal activity.

Authors:  E R Wood; P A Dudchenko; H Eichenbaum
Journal:  Nature       Date:  1999-02-18       Impact factor: 49.962

Review 3.  The hippocampus as an associator of discontiguous events.

Authors:  G V Wallenstein; H Eichenbaum; M E Hasselmo
Journal:  Trends Neurosci       Date:  1998-08       Impact factor: 13.837

4.  Effects of the co-administration of 5-HT1A receptor antagonists with an SSRI in conditioned fear stress-induced freezing behavior.

Authors:  S Hashimoto; T Inoue; T Koyama
Journal:  Pharmacol Biochem Behav       Date:  1997-10       Impact factor: 3.533

5.  Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5-HT1A receptor mRNA in the rat brain.

Authors:  M C Miquel; E Doucet; M Riad; J Adrien; D Vergé; M Hamon
Journal:  Brain Res Mol Brain Res       Date:  1992-08

6.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

7.  The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.

Authors:  H Gozlan; S Thibault; A M Laporte; L Lima; M Hamon
Journal:  Eur J Pharmacol       Date:  1995-01-16       Impact factor: 4.432

8.  The putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin antagonizes the antinociceptive effect of morphine.

Authors:  O G Berge; O B Fasmer; S O Ogren; K Hole
Journal:  Neurosci Lett       Date:  1985-02-28       Impact factor: 3.046

9.  The effects of hippocampal lesions upon spatial and non-spatial tests of working memory.

Authors:  J P Aggleton; P R Hunt; J N Rawlins
Journal:  Behav Brain Res       Date:  1986-02       Impact factor: 3.332

10.  Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.

Authors:  K Tada; K Kasamo; N Ueda; T Suzuki; T Kojima; K Ishikawa
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

View more
  24 in total

1.  Hippocampal lesion effects on occasion setting by contextual and discrete stimuli.

Authors:  Taejib Yoon; Lauren K Graham; Jeansok J Kim
Journal:  Neurobiol Learn Mem       Date:  2010-07-17       Impact factor: 2.877

2.  Functional significance of glycogen synthase kinase-3 regulation by serotonin.

Authors:  Abigail M Polter; Sufen Yang; Richard S Jope; Xiaohua Li
Journal:  Cell Signal       Date:  2011-09-17       Impact factor: 4.315

Review 3.  5-HT1A receptor-regulated signal transduction pathways in brain.

Authors:  Abigail M Polter; Xiaohua Li
Journal:  Cell Signal       Date:  2010-04-02       Impact factor: 4.315

4.  A time-dependent contribution of hippocampal CB1 , CB2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation.

Authors:  Ana Maria Raymundi; Thiago R da Silva; Aleksander R Zampronio; Francisco S Guimarães; Leandro J Bertoglio; Cristina A J Stern
Journal:  Br J Pharmacol       Date:  2020-01-21       Impact factor: 8.739

Review 5.  Transcriptional regulation of the 5-HT1A receptor: implications for mental illness.

Authors:  Paul R Albert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

6.  A role for 5-HT1A receptors in the basolateral amygdala in the development of conditioned defeat in Syrian hamsters.

Authors:  Kathleen E Morrison; Matthew A Cooper
Journal:  Pharmacol Biochem Behav       Date:  2011-09-24       Impact factor: 3.533

7.  Central 5-HT1A receptor-mediated modulation of heart rate dynamics and its adjustment by conditioned and unconditioned fear in mice.

Authors:  Jiun Youn; Torben Hager; Ilga Misane; Anton W Pieneman; René F Jansen; Sven Ove Ogren; Michael Meyer; Oliver Stiedl
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

8.  Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone and altered by chronic amphetamine treatment.

Authors:  J L Barr; G L Forster
Journal:  Neuroscience       Date:  2011-03-21       Impact factor: 3.590

Review 9.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Authors:  Daniela Puzzo; Linda Lee; Agostino Palmeri; Giorgio Calabrese; Ottavio Arancio
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

10.  G Protein-Gated K+ Channel Ablation in Forebrain Pyramidal Neurons Selectively Impairs Fear Learning.

Authors:  Nicole C Victoria; Ezequiel Marron Fernandez de Velasco; Olga Ostrovskaya; Stefania Metzger; Zhilian Xia; Lydia Kotecki; Michael A Benneyworth; Anastasia N Zink; Kirill A Martemyanov; Kevin Wickman
Journal:  Biol Psychiatry       Date:  2015-11-10       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.